Seqens Seqens

X

Find Radio Compass News for Rasagiline

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

SERVICES

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218163

FDA
09 Apr 2024

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-27-2023-3225.pdf

FDA
27 Sep 2023

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-25-2023-68767.pdf

FDA
25 Jan 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201942

FDA
22 Nov 2021

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206153

FDA
09 Oct 2019

https://www.business-standard.com/article/news-cm/indoco-remedies-receives-usfda-approval-for-rasagiline-0-5-mg-and-1-mg-tablets-119100700343_1.html

BUSINESS STANDARD
08 Oct 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201892

FDA
27 Jul 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201889

FDA
30 Oct 2017

http://www.prnewswire.com/news-releases/mylan-launches-generic-azilect-tablets-300467689.html

PR NEWSWIRE
02 Jun 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201971

FDA
16 May 2017

http://www.fiercebiotech.com/venture-capital/pharma-two-b-raises-30m-for-parkinson-s-phase-3-from-biogen-backed-fund-adds-ex

Nick Paul Taylor FIERCE BIOTECH
28 Feb 2017

http://www.drugregulations.org/2016/08/ten-generic-drugs-to-be-withdrawn-in-uk.html

Uday Shetty DRUGREGULATIONS
04 Aug 2016

http://twofourinsight.com/teva-india-patent-application-rasagiline-patch-subject-pre-grant-opposition/

TWO FOUR INSIGHT
02 May 2016

https://www.pharmacompass.com/pdf/news/mylans-rasagiline-approved-in-eu-for-parkinson-disease-1462019745.pdf

EMA
29 Apr 2016

http://www.business-standard.com/article/pti-stories/orchid-gets-final-nod-from-usfda-for-parkinson-s-drug-116031700448_1.html

BUSINESS STANDARD
16 Mar 2016

https://www.pharmacompass.com/pdf/news/orchid-hlthcares-generic-rasagiline-mesylate-approved-in-us-to-treat-symptoms-of-parkinsons-disease-1458298660.pdf

FDA
15 Mar 2016

http://www.pharmatimes.com/Article/16-01-31/Six_medicines_line_up_for_EU_approval.aspx

Selina McKee PHARMATIMES
01 Feb 2016

http://www.courthousenews.com/2015/03/30/creative-kickbacks-at-teva-drug-reps-claim.htm

Lorraine Bailey COURTHOUSE NEWS SERVICE
01 Apr 2015

http://www.fiercepharma.com/story/abbott-puts-one-third-its-6b-mylan-stake-block/2015-03-31

Emily Wasserman FIERCE PHARMA
01 Apr 2015

http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/003957/WC500183463.pdf

Press Release EMA
03 Feb 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY